SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (16632)2/16/2004 5:01:41 PM
From: Robert K.  Respond to of 17367
 
One more point on jacks wording.>">""This pilot study is the first in a series of potential probe studies XOMA is considering to explore various indications for NEUPREX," said John L. Castello"

>this pilot study IS (IS) the first.
>not may be , not might be, not could be,just the word "is"
IMO. maybe nothing, maybe "is" something.
Just a thought.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News